drugset / Trial / NCT02487017
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma
Phase 2
Unknown
60 enrolled
Shenzhen Hornetcorn Bio-technology Company, LTD
Yantai City Hospital for Infectious Diseases · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation of DC-CIK cells combined TACE treatment for HCC
Timeline
- Start
- 2015-05
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DC-CIK | Cell therapy | 8e+09 cells | Intravenous |